Hot News

英國制藥企業葛蘭素史克因欺詐被重罰30億美元 @ 2012-07-04T11: Back Hot News
Keyword:和解 葛蘭素史克 欺詐 醫藥
Concept:896億元新台幣 , 葛蘭素史克支付30億美元和解美國
(綜合報道)(星島日報報道)美國司法部宣布,世界制藥巨頭葛蘭素史克公司(GLAXOSMITHKLINE),已就非法銷售未經核准的藥物等指控認罪,並同意支付三十億美元(二百三十二億港元)和解,成為美國歷史上最大一宗醫藥欺詐和解案。
根據和解協議,葛蘭素史克公司還同意美國政府,今 後5年對其藥物銷售進行更加嚴格的監管,並實施修改管理層薪資支付條件等改革措施,以確保該公司以合法、正常的手段行銷醫藥產品。
涉醫藥欺詐 葛蘭素賠30億美元和解 美醫藥
北京時間7月3日凌晨消息,據外媒報導,制藥巨頭葛蘭素史克已經承認針對公司欺詐的刑事指控,並同意支付30億美元以和解相關案件。這將是美國歷史上最大的一起醫療保健欺詐案件。

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.